Your browser doesn't support javascript.
loading
Bioinspired chitosan based functionalization of biomedical implant surfaces for enhanced hemocompatibility, antioxidation and anticoagulation potential: an in silico and in vitro study.
Hassan, Sadia; Bilal, Namra; Khan, Tooba Javaid; Ali, Murtaza Najabat; Ghafoor, Bakhtawar; Saif, Khawaja Usman.
Afiliación
  • Hassan S; School of Mechanical and Manufacturing Engineering (SMME), National University of Sciences and Technology Islamabad Pakistan shassan.phd20smme@student.nust.edu.pk.
  • Bilal N; Nencki Institute of Experimental Biology Poland.
  • Khan TJ; School of Mechanical and Manufacturing Engineering (SMME), National University of Sciences and Technology Islamabad Pakistan shassan.phd20smme@student.nust.edu.pk.
  • Ali MN; School of Mechanical and Manufacturing Engineering (SMME), National University of Sciences and Technology Islamabad Pakistan shassan.phd20smme@student.nust.edu.pk.
  • Ghafoor B; School of Mechanical and Manufacturing Engineering (SMME), National University of Sciences and Technology Islamabad Pakistan shassan.phd20smme@student.nust.edu.pk.
  • Saif KU; Isra University Islamabad Pakistan.
RSC Adv ; 14(29): 20691-20713, 2024 Jun 27.
Article en En | MEDLINE | ID: mdl-38952927
ABSTRACT
Endowing implanted biomaterials with better hemocompatibility, anticoagulation, antioxidant and antiplatelet adhesion is necessary because of their potential to trigger activation of multiple reactive mechanisms including coagulation cascade and potentially causing serious adverse clinical events like late thrombosis. Active ingredients from natural sources including Foeniculum vulgare, Angelica sinensis, and Cinnamomum verum have the ability to inhibit the coagulation cascade and thrombus formation around biomedical implants. These properties are of interest for the development of a novel drug for biomedical implants to potentially solve the current blood clotting and coagulation problems which lead to stent thrombosis. The objective of this study was to incorporate different anticoagulants from natural sources into a degradable matrix of chitosan with varying concentrations ranging from 5% to 15% and a composite containing all three drugs. The presence of anticoagulant constituents was identified using GC-MS. Subsequently, all the compositions were characterized principally by using Fourier transform infrared spectroscopy and scanning electron microscopy while the drug release profile was determined using UV-spectrometry for a 30 days immersion period. The results indicated an initial burst release which was subsequently followed by the sustained release pattern. Compared to heparin loaded chitosan, DPPH and hemolysis tests revealed better blood compatibility of natural drug loaded films. Moreover, the anticoagulation activity of natural drugs was equivalent to the heparin loaded film; however, through docking, the mechanism of inhibition of the coagulation cascade of the novel drug was found to be through blocking the extrinsic pathway. The study suggested that the proposed drug composite expresses an optimum composition which may be a practicable and appropriate candidate for biomedical implant coatings.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: RSC Adv Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: RSC Adv Año: 2024 Tipo del documento: Article